Ge Bai on the IRA, CBO Insights, and Long-Term Care Financial Burdens

In this conversation, Joe Grogan and Ge Bai discuss the complexities of healthcare finance, focusing on the Inflation Reduction Act (IRA) and its implications for drug pricing and Medicare. They delve into the role of the Congressional Budget Office (CBO) in estimating the financial impacts of healthcare policies, highlighting the discrepancies between projected savings and actual costs. The discussion also touches on the challenges faced by seniors under Medicare Part D, the potential consequences for drug innovation, and the need for bipartisan solutions in healthcare reform. Additionally, they explore the implications of proposed long-term care policies and the financial burdens they may impose.